Here's What Key Metrics Tell Us About Aspen Aerogels (ASPN) Q3 Earnings

07.11.25 04:00 Uhr

Werte in diesem Artikel
Aktien

3,86 USD -0,25 USD -6,08%

Aspen Aerogels (ASPN) reported $73.02 million in revenue for the quarter ended September 2025, representing a year-over-year decline of 37.8%. EPS of -$0.06 for the same period compares to $0.11 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $74.39 million, representing a surprise of -1.85%. The company has not delivered EPS surprise, with the consensus EPS estimate being $0.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Aspen Aerogels performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Revenue- Energy Industrial: $24.3 million versus $26.48 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -9.3% change.Revenue- Thermal Barrier: $48.7 million versus the two-analyst average estimate of $46.81 million. The reported number represents a year-over-year change of -46.3%.Gross Profit- Thermal Barrier: $11.93 million versus the two-analyst average estimate of $15.15 million.Gross Profit- Energy Industrial: $8.87 million versus the two-analyst average estimate of $9.49 million.View all Key Company Metrics for Aspen Aerogels here>>>Shares of Aspen Aerogels have returned -10.8% over the past month versus the Zacks S&P 500 composite's +1.3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Aspen Aerogels, Inc. (ASPN): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Aspen Aerogels

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Aspen Aerogels

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Aspen Aerogels Inc

Wer­bung

Analysen zu Aspen Aerogels Inc

DatumRatingAnalyst
24.02.2017Aspen Aerogels BuyNeedham & Company, LLC
04.11.2016Aspen Aerogels NeutralSeaport Global Securities
20.09.2016Aspen Aerogels BuyCraig Hallum
12.08.2015Aspen Aerogels BuyGlobal Hunter Securities
10.08.2015Aspen Aerogels BuyNeedham & Company, LLC
DatumRatingAnalyst
24.02.2017Aspen Aerogels BuyNeedham & Company, LLC
20.09.2016Aspen Aerogels BuyCraig Hallum
12.08.2015Aspen Aerogels BuyGlobal Hunter Securities
10.08.2015Aspen Aerogels BuyNeedham & Company, LLC
07.08.2015Aspen Aerogels BuyCanaccord Adams
DatumRatingAnalyst
04.11.2016Aspen Aerogels NeutralSeaport Global Securities
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Aspen Aerogels Inc nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen